Tortoise Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,988
Closed -$4.3K 825
2023
Q3
$4.3K Hold
2,988
﹤0.01% 632
2023
Q2
$7.44K Hold
2,988
﹤0.01% 589
2023
Q1
$8.01K Hold
2,988
﹤0.01% 573
2022
Q4
$16.2K Hold
2,988
﹤0.01% 487
2022
Q3
$37K Hold
2,988
0.01% 353
2022
Q2
$15K Hold
2,988
﹤0.01% 471
2022
Q1
$23K Hold
2,988
﹤0.01% 411
2021
Q4
$31K Hold
2,988
0.01% 346
2021
Q3
$40K Hold
2,988
0.01% 301
2021
Q2
$66K Hold
2,988
0.01% 238
2021
Q1
$72K Hold
2,988
0.02% 226
2020
Q4
$54K Hold
2,988
0.01% 235
2020
Q3
$35K Hold
2,988
0.01% 257
2020
Q2
$72K Hold
2,988
0.02% 200
2020
Q1
$33K Hold
2,988
0.01% 255
2019
Q4
$79K Hold
2,988
0.02% 208
2019
Q3
$68K Hold
2,988
0.02% 209
2019
Q2
$92K Hold
2,988
0.02% 195
2019
Q1
$50K Hold
2,988
0.01% 251
2018
Q4
$57K Hold
2,988
0.02% 221
2018
Q3
$156K Hold
2,988
0.04% 158
2018
Q2
$130K Sell
2,988
-2,623
-47% -$112K 0.04% 167
2018
Q1
$208K Buy
+5,611
New +$150K 0.06% 133

Other funds holding GTHX

Tortoise Investment Management's GTHX Position: Q4 2023 in Review

Tortoise Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2023, closing a stake of 2,988 shares — an estimated $4.3K sold.

Tortoise Investment Management first reported a position in GTHX in Q1 2018 and held it in 23 quarters. The position peaked at $208K in Q1 2018. 87 funds tracked by Wall St. Rank hold GTHX as of Q4 2023.

  • Tortoise Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tortoise Investment Management sold 2,988 G1 Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $4.3K.
  • Tortoise Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 23 quarters.
  • Tortoise Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $208K in Q1 2018.
  • 87 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Tortoise Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.